BRC Investment Management’s Charles River Laboratories CRL Stock Holding History

BRC Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$716K	Buy	8,595 +3	+0%	+$251	0.12%	151
2016 Q2	$708K	Sell	8,592 -970	-10%	-$79.9K	0.12%	88
2016 Q1	$726K	Sell	9,562 -27	-0.3%	-$2K	0.11%	70
2015 Q4	$771K	Buy	+9,589	New	+$692K	0.11%	62
2015 Q2	–	Sell	-8,829	Closed	-$700K	–	123
2015 Q1	$700K	Sell	8,829 -1,238	-12%	-$91.3K	0.1%	72
2014 Q4	$641K	Buy	10,067 +1,510	+18%	+$94.7K	0.09%	84
2014 Q3	$511K	Sell	8,557 -27	-0.3%	-$1.54K	0.08%	88
2014 Q2	$459K	Sell	8,584 -82	-0.9%	-$4.5K	0.07%	120
2014 Q1	$523K	Buy	+8,666	New	+$505K	0.08%	102

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BRC Investment Management's CRL Position: Q3 2016 in Review

BRC Investment Management increased its Charles River Laboratories (CRL) stake by 0.03% in Q3 2016, buying an estimated $251 and bringing the position to 8,595 shares worth $716K. The position accounts for 0.12% of the portfolio, ranked #151.

BRC Investment Management first reported a position in CRL in Q1 2014 and has held it in 9 quarters since. The position peaked at $771K in Q4 2015. 283 funds tracked by Wall St. Rank hold CRL as of Q3 2016.

BRC Investment Management held 8,595 shares of Charles River Laboratories worth $716K as of Q3 2016.
BRC Investment Management bought 3 Charles River Laboratories shares in Q3 2016, an estimated $251.
Charles River Laboratories made up 0.12% of BRC Investment Management's portfolio in Q3 2016, its #151 holding.
BRC Investment Management first reported a position in Charles River Laboratories in Q1 2014 and has held it in 9 quarters since.
BRC Investment Management's Charles River Laboratories position peaked at $771K in Q4 2015.
283 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2016.

Based on BRC Investment Management's 13F filing for Q3 2016, filed 31 Oct 2016.